Plasminogen Activity

Synonyms

  • FACTORS
  • FIBRINOLYTIC
  • INHIBITORS
  • LAB847
  • plasmin F
  • PLASMINOGEN ACTIVITY

Cerner Name

PLASMIN F

Clinical Info

Monitor thrombolytic therapy; evaluate ligneous tissue depositions such as conjunctivitis

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

Blood

Specimen Volume

2 ml plasma ( 1 mL min)

Container

Blue Top

Collection Instructions

Container/Tube: Light-blue top (3.2% sodium citrate) tube
Specimen: 2 ml plasma ( 1 mL min)
Transport Temperature: Frozen  Please send separate tube for each test requested-cannot share frozen samples
Patient Preparation
Ideally, the patient should not be on anticoagulant therapy. Avoid warfarin (Coumadin®) therapy for two weeks prior to the test and heparin, direct Xa, and thrombin inhibitor therapies for about three days prior to testing. Do not draw from an arm with a heparin lock or heparinized catheter.
 

Transport Instructions

Frozen  Please send separate tube for each test requested-cannot share frozen samples

Specimen Stability

Methodology

Colorimetric

Days Performed

Monday through Sunday
Turn around Time 7-10 Days

Performing Laboratories

LabCorp Burlington

CPT

85420

PDM

5500608

Results
Component Name Base Name Common Name External Name
PLASMINOGEN ACTIVITY PLASMINACT PLASMINOGEN ACTIVITY Plasminogen Activity

Result Interpretation

Adult: 70 % - 150%
In newborns, ranges are about 50% of adult levels and even lower concentrations occur in premature infants. Levels can become markedly increased during the second and third trimesters of pregnancy.

Forms
Hematology LAB847 build edit